- SynAm Vaccine
- Rockville Innovation Center
- 155 Gibbs Street, #552
- Rockville, Maryland 20850
for investment and partnering inquiries:
- Carolyn Chen
- Vice President, Business Development
SynAm Vaccine's mission is to eradicate pneumococcal diseases — pneumonia, middle ear infections, and meningitis — with the world's first universal vaccine. Pneumococcal diseases are the leading cause of serious illness in children and adults throughout the world and account for more deaths than all other vaccine-preventable bacterial diseases combined.
SynAm Vaccine's lead universal vaccine candidate addresses the critical unmet medical need in the marketplace by providing universal coverage against all 91 bacteria serotypes, while current marketed vaccines cover only a fraction of the serotypes.